Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Usana Health Sciences (USNA) Gross Margin (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Gross Margin for 17 consecutive years, with 78.16% as the latest value for Q1 2026.

  • Quarterly Gross Margin fell 379.0% to 78.16% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 78.29% through Jan 2026, down 284.0% year-over-year, with the annual reading at 78.29% for FY2026, 284.0% down from the prior year.
  • Gross Margin for Q1 2026 was 78.16% at Usana Health Sciences, up from 77.15% in the prior quarter.
  • The five-year high for Gross Margin was 81.95% in Q4 2024, with the low at 77.15% in Q3 2025.
  • Average Gross Margin over 5 years is 80.24%, with a median of 80.46% recorded in 2023.
  • The sharpest move saw Gross Margin surged 123bps in 2023, then plummeted -379bps in 2026.
  • Over 5 years, Gross Margin stood at 79.63% in 2022, then increased by 2bps to 80.86% in 2023, then rose by 1bps to 81.95% in 2024, then decreased by -6bps to 77.15% in 2025, then rose by 1bps to 78.16% in 2026.
  • According to Business Quant data, Gross Margin over the past three periods came in at 78.16%, 77.15%, and 78.72% for Q1 2026, Q3 2025, and Q2 2025 respectively.